PM2.5 exposure aggravates oligomeric amyloid beta-induced neuronal injury and promotes NLRP3 inflammasome activation in an in vitro model of Alzheimer’s disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1742-2094

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: PM2.5 exposure aggravates oligomeric amyloid beta-induced neuronal injury and promotes NLRP3 inflammasome activation in an in vitro model of Alzheimer’s disease ; volume:15 ; number:1 ; day:2 ; month:5 ; year:2018 ; pages:1-12 ; date:12.2018
Journal of neuroinflammation ; 15, Heft 1 (2.5.2018), 1-12, 12.2018

Creator: Wang, Bian-Rong

Contributor: Shi, Jian-Quan
Ge, Nian-Nian
Ou, Zhou
Tian, You-Yong
Jiang, Teng
Zhou, Jun-Shan
Xu, Jun
Zhang, Ying-Dong
SpringerLink (Online service)

DOI: 10.1186/s12974-018-1178-5

URN: urn:nbn:de:101:1-2018070423393477261419

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:24 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Wang, Bian-Rong
Shi, Jian-Quan
Ge, Nian-Nian
Ou, Zhou
Tian, You-Yong
Jiang, Teng
Zhou, Jun-Shan
Xu, Jun
Zhang, Ying-Dong
SpringerLink (Online service)

Other Objects (12)

Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease

LATE-NC aggravates GVD-mediated necroptosis in Alzheimer’s disease

Inflammasome activation aggravates choroidal neovascularization

β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology

Formation of Toxic Oligomeric Assemblies of RNA-binding Protein: Musashi in Alzheimer’s disease

CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer’s disease

Cerebral amyloid angiopathy aggravates perivascular clearance impairment in an Alzheimer’s disease mouse model

Associations between PM2.5 exposure and Alzheimer’s Disease prevalence Among elderly in eastern China

Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer’s disease

Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease

Liver-specific adiponectin gene therapy suppresses microglial NLRP3-inflammasome activation for treating Alzheimer’s disease

Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease

Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease

LATE-NC aggravates GVD-mediated necroptosis in Alzheimer’s disease

Inflammasome activation aggravates choroidal neovascularization

β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology

Formation of Toxic Oligomeric Assemblies of RNA-binding Protein: Musashi in Alzheimer’s disease

CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer’s disease

Cerebral amyloid angiopathy aggravates perivascular clearance impairment in an Alzheimer’s disease mouse model

Associations between PM2.5 exposure and Alzheimer’s Disease prevalence Among elderly in eastern China

Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer’s disease

Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease

Liver-specific adiponectin gene therapy suppresses microglial NLRP3-inflammasome activation for treating Alzheimer’s disease

Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease

Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease

LATE-NC aggravates GVD-mediated necroptosis in Alzheimer’s disease

Inflammasome activation aggravates choroidal neovascularization

β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology

Formation of Toxic Oligomeric Assemblies of RNA-binding Protein: Musashi in Alzheimer’s disease

CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer’s disease

Cerebral amyloid angiopathy aggravates perivascular clearance impairment in an Alzheimer’s disease mouse model

Associations between PM2.5 exposure and Alzheimer’s Disease prevalence Among elderly in eastern China

Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer’s disease

Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease

Liver-specific adiponectin gene therapy suppresses microglial NLRP3-inflammasome activation for treating Alzheimer’s disease

Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

PM2.5 exposure aggravates oligomeric amyloid beta-induced neuronal injury and promotes NLRP3 inflammasome activation in an in vitro model of Alzheimer’s disease

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease

LATE-NC aggravates GVD-mediated necroptosis in Alzheimer’s disease

Inflammasome activation aggravates choroidal neovascularization

β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology

Formation of Toxic Oligomeric Assemblies of RNA-binding Protein: Musashi in Alzheimer’s disease

CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer’s disease

Cerebral amyloid angiopathy aggravates perivascular clearance impairment in an Alzheimer’s disease mouse model

Associations between PM2.5 exposure and Alzheimer’s Disease prevalence Among elderly in eastern China

Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer’s disease

Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease

Liver-specific adiponectin gene therapy suppresses microglial NLRP3-inflammasome activation for treating Alzheimer’s disease

Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease

Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease

LATE-NC aggravates GVD-mediated necroptosis in Alzheimer’s disease

Inflammasome activation aggravates choroidal neovascularization

β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology

Formation of Toxic Oligomeric Assemblies of RNA-binding Protein: Musashi in Alzheimer’s disease

CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer’s disease

Cerebral amyloid angiopathy aggravates perivascular clearance impairment in an Alzheimer’s disease mouse model

Associations between PM2.5 exposure and Alzheimer’s Disease prevalence Among elderly in eastern China

Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer’s disease

Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease

Liver-specific adiponectin gene therapy suppresses microglial NLRP3-inflammasome activation for treating Alzheimer’s disease

Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease

Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease

LATE-NC aggravates GVD-mediated necroptosis in Alzheimer’s disease

Inflammasome activation aggravates choroidal neovascularization

β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology

Formation of Toxic Oligomeric Assemblies of RNA-binding Protein: Musashi in Alzheimer’s disease

CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer’s disease

Cerebral amyloid angiopathy aggravates perivascular clearance impairment in an Alzheimer’s disease mouse model

Associations between PM2.5 exposure and Alzheimer’s Disease prevalence Among elderly in eastern China

Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer’s disease

Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease

Liver-specific adiponectin gene therapy suppresses microglial NLRP3-inflammasome activation for treating Alzheimer’s disease

Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease

Related objects

Reset password